#biotech

Last 7 Days 📉 Bearish 📉1

Last 30 Days 📈 Bullish 📈7 📉2 📊1

📈 Stocks XLV 📉 Bearish

Clashes, Turmoil and Paranoia: Inside Trump’s FDA

May 8, 2026 (50 days ago)

FDA gridlock clouds drug approval timelines, pressuring healthcare stocks and ETFs like XLV and IBB.

▼ Escalating reports of FDA dysfunction deepen sector uncertainty.

📅 Short 🌍 US Read More →